Katherine K Clifton
11PUBLICATIONS
77CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 21, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.Foluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher
|Dec 17, 2024
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast Cancer.Lis Victoria Ravani, Pedro Calomeni, Maysa Vilbert
|Jun 02, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton
|May 04, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis.Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic
|Jan 24, 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.Andrew A Davis, Jingqin Luo, Tiantian Zheng
Pageof 2
Frequent Collaborators
4 joint publications
Cynthia X Ma
3 joint publications
Andrew Davis
3 joint publications
Lindsay L Peterson
3 joint publications
Foluso O Ademuyiwa
2 joint publications
Lorenzo Gerratana
2 joint publications
Marko Velimirovic
2 joint publications
Rama Suresh
2 joint publications
Caron Rigden
2 joint publications
Ashley Frith
2 joint publications
Katherine Weilbaecher
